Following on the heels of the approval granted to Apple Watch Series 4 for ECG screening, the US FDA has now given the green signal to another wearable mHealth device - the Embrace smartwatch. The Embrace smartwatch has been approved to monitor seizure activity in children as young as age 6. Its use in adults had been approved last February. The watch uses advanced machine learning technology to detect patterns in motion and physiological signals that may be associated with generalized tonic-clonic seizures.
It then immediately alerts parents and/or the nominated caregivers, via text and phone messages, allowing them to quickly respond. It also provides sleep, rest, and physical activity analysis. Its unique property is its use of the electrodermal activity, a signal used by stress researchers to quantify physiological changes related to sympathetic nervous system activity, also known…
